News about Drug Discovery & Development

Marksans Pharma announces UK MHRA approval for Fluoxetine 20mg/5ml oral solution

The product will be manufactured at the plant of Bell, Sons & Co, UK

Drug Discovery & Development | 24/01/2023 | By Sudeep Soparkar |  588

Eurofins CDMO Alphora expands API development labs

The 56,000-square foot building is the new home of Eurofins CDMO Alphora’s API process R&D activity, solid-state R&D activity and its analytical services team

Drug Discovery & Development | 17/01/2023 | By Sudeep Soparkar |  795

AstraZeneca partners with Australia-based LBT Innovations for new pharma product line

AstraZeneca will fund the development of the APAS Pharma analysis module and validate the final product for their processes
<br />

Drug Discovery & Development | 12/01/2023 | By Sudeep Soparkar |  725

Glenmark Pharma launches Bumetanide Injection in single and multi-dose vials

The product is the generic version of Bumex 1 Injection, 0.25 mg/mL, of Validus Pharmaceuticals

Drug Discovery & Development | 11/01/2023 | By Sudeep Soparkar |  780

Zydus launches Topiramate extended-release capsules

Zydus is the first company to receive final approval and launch Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg in the US
<br />

Drug Discovery & Development | 07/01/2023 | By Sudeep Soparkar |  772

Asymchem opens R&D site near Boston, Massachusetts

The new Boston site is focussed on providing early-stage R&D services including chemical process development, pre-formulation study and formulation development
<br />

Drug Discovery & Development | 20/12/2022 | By Sudeep Soparkar |  805

Freudenberg Medical unveils HelixFlex at CPhI & PMEC India

TPE tubing is ideal for pharmaceutical bioprocessing applications

Drug Discovery & Development | 30/11/2022 | By Sudeep Soparkar |  798

Cipla unveils Leuprolide Acetate Injection Depot 22.5mg

The injection is indicated for the palliative treatment of advanced prostate cancer

Drug Discovery & Development | 29/11/2022 | By Sudeep Soparkar |  956

NATCO Pharma launches Pomalyst caps in Australia

The product was launched by NATCO’s commercial partner Juno Pharmaceuticals

Drug Discovery & Development | 09/11/2022 | By Sudeep Soparkar |  1104

Glenmark launches Teneligliptin + Dapagliflozin Fixed-Dose Combination for adults with Type 2 diabetes

With this new launch, the company aims to improve glycemic control in adult patients with uncontrolled type 2 diabetes

Drug Discovery & Development | 21/10/2022 | By Sudeep Soparkar |  615